Mitolactol chemotherapy for malignant melanoma: a phase II study.
作者信息
Malden L T, Coates A S, Milton G W, McCarthy W H, Levi J A, Woods R L, Byrne M J, Reynolds P M, Fox R M, Hedley D W
出版信息
Cancer Treat Rep. 1984 Jul-Aug;68(7-8):1045-6.
PMID:6744338
Abstract
Fifty-one patients (43 evaluable) with malignant melanoma were treated with mitolactol in an intermittent oral schedule. There were four objective tumor responses, all occurring in patients previously treated with dacarbazine.
摘要
Zotero 插件